Salvatore Novello
Affiliations: | EPFL - Brain Mind Institute, Lausanne, Vaud, Switzerland |
Area:
Neurodegeneration, Parkinson's Disease, Protein aggregation, LRRK2, MicrodialysisGoogle:
"Salvatore Novello"Mean distance: (not calculated yet)
Parents
Sign in to add mentorMark R. Cookson | grad student | 2018-2018 | National Institute on Aging Intramural Research Program |
Erwan Bezard | grad student | 2014-2019 | Université de Bordeaux |
Michele Morari | grad student | 2015-2019 | Università degli Studi di Ferrara (FlyTree) |
Hilal A. Lashuel | post-doc | 2019- | EPFL - Brain Mind Institute (Chemistry Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Lashuel HA, Mahul-Mellier AL, Novello S, et al. (2022) Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity. Npj Parkinson's Disease. 8: 136 |
Teixidor J, Novello S, Ortiz D, et al. (2022) On-Demand Nanoliter Sampling Probe for the Collection of Brain Fluid. Analytical Chemistry |
Domenicale C, Mercatelli D, Albanese F, et al. (2022) Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice. Biomedicines. 10 |
Novello S, Mercatelli D, Albanese F, et al. (2022) In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity. Neurobiology of Disease. 162: 105579 |
Sarti AC, Vultaggio-Poma V, Falzoni S, et al. (2021) Mitochondrial P2X7 Receptor Localization Modulates Energy Metabolism Enhancing Physical Performance. Function (Oxford, England). 2: zqab005 |
Lashuel HA, Novello S. (2021) Lewy body-associated proteins: Victims, instigators, or innocent bystanders? The case of AIMP2 and alpha-synuclein. Neurobiology of Disease. 105417 |
Regoni M, Zanetti L, Comai S, et al. (2021) Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse Biomedicines |
Regoni M, Zanetti L, Comai S, et al. (2021) Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse. Biomedicines. 9 |
Regoni M, Cattaneo S, Mercatelli D, et al. (2020) Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity. Cell Death & Disease. 11: 963 |
Bourdenx M, Nioche A, Dovero S, et al. (2020) Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates. Science Advances. 6: eaaz9165 |